Deliver safe, evidence-based GLP-1 prescribing for every patient, taking full ownership of clinical quality.
Run detailed consultations that capture everything first time, tracking treatment response and escalating red flags.
Maintain accurate clinical records, contribute to audits, and collaborate with support, operations, and tech teams.
AIOS is building the world's first full-stack AI doctor, serving 150k patients monthly via Bolt Pharmacy. The company is at $400M ARR, profitable, and growing rapidly with a young, founder-led culture.
Clinically check prescriptions accurately and efficiently using the online pharmacy platform.
Ensure prescriptions are reviewed and progressed within agreed SLAs and turnaround times.
Maintain consistent checking volumes without compromising clinical accuracy or patient safety.
Montu UK is a leading digital health company specialising in cannabis-based medicines, committed to transforming lives by improving access to safe treatments. They offer a dynamic, collaborative, and supportive working environment.
Deliver safe, evidence-based GLP-1 prescribing and take full accountability for daily clinical quality, safety, and governance of your team.
Lead clinicians in a fast-moving telehealth environment, set clear standards on prescribing quality, audit, and escalation.
Translate new evidence and regulatory guidance into practical clinical protocols and provide feedback to product teams.
AIOS is building the world's first full-stack AI doctor, serving 150k patients per month via Bolt Pharmacy in the UK. The company is at $350M ARR, growing rapidly from $10M a year ago, and is profitable with a young, founder-led culture.
Evaluate patient consultations via an asynchronous online platform and determine prescribing needs.
Prescribe GLP-1 weight-loss treatments in accordance with clinical protocols and local regulations.
Collaborate with customer support and healthcare professionals to provide patient care via email, phone, or video.
HeliosX is a digital healthcare platform that provides faster, more accessible healthcare through vertical integration and proprietary products. The company treated over 1.7 million patients globally in 2025, reaching £781m in revenue, and operates across four international markets.